Skip to main content

Table 1 Baseline characteristics of the cohort

From: Cancer development in patients with COPD: a retrospective analysis of the National Health Insurance Service-National Sample Cohort in Korea

 

Never smoker

Former smoker

Smoker

 

No COPD

COPD

No COPD

COPD

No COPD

COPD

P

Number

313,553 (65.45)

7789 (1.63)

41,359 (8.63)

1085 (0.23)

112,627 (23.51)

2677 (0.56)

 

Age (years)

53.64 ± 9.62

62.23 ± 9.87

51.65 ± 9.12

62.43 ± 10.16

50.92 ± 8.74

61.29 ± 9.83

< 0.001

Gender (male), N (%)

107,393 (34.25)

2799 (35.94)

39,292 (95.00)

1005 (92.63)

106,695 (94.73)

2368 (88.46)

< 0.001

BMI (kg/m2)

24.08 ± 3.01

24.02 ± 3.39

24.31 ± 2.73

23.18 ± 3.05

23.73 ± 2.94

22.97 ± 3.28

< 0.001

  < 20

23,181 (7.39)

847 (10.87)

2205 (5.33)

157 (14.47)

11,102 (9.86)

514 (19.20)

< 0.001

 20 ≤ < 25

178,681 (56.99)

4071 (52.27)

22,958 (55.51)

642 (59.17)

65,174 (57.87)

1466 (54.76)

< 0.001

 25 ≤ < 30

101,536 (32.38)

2556 (32.82)

15,247 (36.87)

265 (24.42)

34,045 (30.23)

633 (23.65)

< 0.001

 30 ≤

10,155 (3.24)

315 (4.04)

949 (2.29)

21 (1.94)

2306 (2.05)

64 (2.39)

< 0.001

Systolic blood pressure (mmHg)

126.71 ± 18.55

130.61 ± 19.21

128.56 ± 17.16

130.07 ± 18.70

127.71 ± 17.55

128.88 ± 18.59

< 0.001

Diastolic blood pressure (mmHg)

97.28 ± 33.29

100.50 ± 38.18

99.56 ± 32.21

101.26 ± 44.08

100.40 ± 37.72

101.86 ± 34.78

< 0.001

Fasting serum glucose (mg/dL)

200.88 ± 38.50

201.56 ± 39.47

201.17 ± 37.52

196.79 ± 42.59

199.10 ± 38.39

195.80 ± 42.63

< 0.001

Total cholesterol (mg/dL)

313,553 (65.45)

7789 (1.63)

41,359 (8.63)

1085 (0.23)

112,627 (23.51)

2677 (0.56)

< 0.001

Exercise level

 Non exercise

187,422(60.81)

5387 (70.08)

16,159 (39.74)

619 (58.18)

59,485 (52.97)

1848 (69.42)

< 0.001

 Once or twice a week

63,023 (20.45)

1078 (14.02)

13,986 (34.40)

239 (22.46)

33,756 (30.06)

450 (16.90)

 At least three times a week

57,778 (18.75)

1225 (15.90)

10,517 (25.86)

206 (19.36)

19,063 (16.97)

364 (13.67)

Incident rate of lung cancer per 100,000 person year: average of six arms = 278

216

757

271

1266

394

1560

<  0.001

Prevalence of cancer for 12 years, N (%)

 Lung cancer (C33-C34)

7669 (2.44)

609 (7.82)

1263 (3.05)

129 (11.89)

4899 (4.35)

398 (14.87)

< 0.001

 Stomach cancer (C16)

7979 (2.54)

310 (3.98)

1464 (3.54)

64 (5.90)

4170 (3.70)

143 (5.34)

< 0.001

 Colorectal cancer (C18-C20)

12,126 (3.87)

505 (6.48)

1847 (4.47)

65 (5.99)

4783 (4.25)

203 (7.58)

< 0.001

 Liver cancer (C22)

12,681 (4.04)

446 (5.73)

2091 (5.06)

81 (7.47)

6131 (5.44)

188 (7.02)

< 0.001

 AML (C92.0)

181 (0.06)

5 (0.06)

19 (0.05)

1 (0.09)

74 (0.07)

3 (0.11)

0.600

 Esophageal cancer (C15)

463 (0.15)

29 (0.37)

124 (0.30)

3 (0.28)

474 (0.42)

15 (0.56)

< 0.001

 Bladder cancer (C67)

2367 (0.75)

100 (1.28)

426 (1.03)

18 (1.66)

1083 (0.96)

39 (1.46)

< 0.001

 Kidney cancer (C64-C66)

1740 (0.55)

58 (0.74)

276 (0.67)

12 (1.11)

729 (0.65)

24 (0.90)

< 0.001

Past medical history, N (%)

 Hypertension

29,436 (9.39)

1257 (16.14)

3334 (8.06)

143 (13.18)

5974 (5.30)

282 (10.53)

< 0.001

 Diabetes mellitus

12,904 (4.12)

539 (6.92)

1949 (4.71)

65 (5.99)

4559 (4.05)

173 (6.46)

< 0.001

  1. Definition of abbreviations: AML Acute myeloid leukemia, BMI Body mass index, COPD Chronic obstructive pulmonary disease